[1]
Kamal, R.B. 2023. Risk Assessment of Cyclophosphamide and Mycophenolate Mofetil after Induction Treatment of Lupus Nephritis: A Single Center Quasi-Experimental Study. Chattagram Maa-O-Shishu Hospital Medical College Journal. 22, 1 (Jul. 2023), 28–32. DOI:https://doi.org/10.3329/cmoshmcj.v22i1.67831.